Global Glaucoma Therapeutics Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 95

Report ID: 19417

Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve, may result in vision loss and blindness. Factors such, high prevalence of glaucoma, technological advancement in diagnostic technique, rising treatment awareness are driving the market growth of glaucoma therapeutics globally.
The change in the lifestyle of people has resulted in the rise in the prevalence of glaucoma globally. Increasing prevalence of glaucoma is the primary factor driving the growth of glaucoma therapeutics market around the globe. Glaucoma is more prevalent among the people above the age of 60. Rising geriatric population thought the globe is also responsible for the robust growth of glaucoma therapeutics market over the forecast period. Increasing preference of physician towards the laser surgery for the treatment of glaucoma will propel the growth of glaucoma therapeutics market over the forecast period. Less awareness among the people about the glaucoma treatment will deter the growth of glaucoma therapeutics market to some extent. Moreover, lack of availability of skilled professional for laser surgery in under developing economies will also hamper the growth of glaucoma therapeutics market.
The consumption of glaucoma drugs in the Americas is increasing due to the rising incidence of glaucoma in countries such as the US. Owing to its heavy investments in the healthcare sector, the US the major revenue contributor to the glaucoma therapeutics market in this region. With the presence of pharmaceutical giants and huge investments in the pharmaceutical industry, the need for glaucoma therapeutics will increase in the region during the predicted period.
In 2018, the global Glaucoma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Glaucoma Therapeutics development in United States, Europe and China.

The key players covered in this study
Allergan
Pfizer
Novartis
Merck
...

Market segment by Type, the product can be split into
Prostaglandin Analogs
Beta Blockers
Alpha Agonists
Carbonic Anhydrase Inhibitors

Market segment by Application, split into
Ophthalmic Clinic
Hospitals
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Glaucoma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Glaucoma Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Glaucoma Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Glaucoma Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Prostaglandin Analogs
1.4.3 Beta Blockers
1.4.4 Alpha Agonists
1.4.5 Carbonic Anhydrase Inhibitors
1.5 Market by Application
1.5.1 Global Glaucoma Therapeutics Market Share by Application (2014-2025)
1.5.2 Ophthalmic Clinic
1.5.3 Hospitals
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Glaucoma Therapeutics Market Size
2.2 Glaucoma Therapeutics Growth Trends by Regions
2.2.1 Glaucoma Therapeutics Market Size by Regions (2014-2025)
2.2.2 Glaucoma Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Glaucoma Therapeutics Market Size by Manufacturers
3.1.1 Global Glaucoma Therapeutics Revenue by Manufacturers (2014-2019)
3.1.2 Global Glaucoma Therapeutics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Glaucoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Glaucoma Therapeutics Key Players Head office and Area Served
3.3 Key Players Glaucoma Therapeutics Product/Solution/Service
3.4 Date of Enter into Glaucoma Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Glaucoma Therapeutics Market Size by Type (2014-2019)
4.2 Global Glaucoma Therapeutics Market Size by Application (2014-2019)

5 United States
5.1 United States Glaucoma Therapeutics Market Size (2014-2019)
5.2 Glaucoma Therapeutics Key Players in United States
5.3 United States Glaucoma Therapeutics Market Size by Type
5.4 United States Glaucoma Therapeutics Market Size by Application

6 Europe
6.1 Europe Glaucoma Therapeutics Market Size (2014-2019)
6.2 Glaucoma Therapeutics Key Players in Europe
6.3 Europe Glaucoma Therapeutics Market Size by Type
6.4 Europe Glaucoma Therapeutics Market Size by Application

7 China
7.1 China Glaucoma Therapeutics Market Size (2014-2019)
7.2 Glaucoma Therapeutics Key Players in China
7.3 China Glaucoma Therapeutics Market Size by Type
7.4 China Glaucoma Therapeutics Market Size by Application

8 Japan
8.1 Japan Glaucoma Therapeutics Market Size (2014-2019)
8.2 Glaucoma Therapeutics Key Players in Japan
8.3 Japan Glaucoma Therapeutics Market Size by Type
8.4 Japan Glaucoma Therapeutics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Glaucoma Therapeutics Market Size (2014-2019)
9.2 Glaucoma Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Glaucoma Therapeutics Market Size by Type
9.4 Southeast Asia Glaucoma Therapeutics Market Size by Application

10 India
10.1 India Glaucoma Therapeutics Market Size (2014-2019)
10.2 Glaucoma Therapeutics Key Players in India
10.3 India Glaucoma Therapeutics Market Size by Type
10.4 India Glaucoma Therapeutics Market Size by Application

11 Central & South America
11.1 Central & South America Glaucoma Therapeutics Market Size (2014-2019)
11.2 Glaucoma Therapeutics Key Players in Central & South America
11.3 Central & South America Glaucoma Therapeutics Market Size by Type
11.4 Central & South America Glaucoma Therapeutics Market Size by Application

12 International Players Profiles
12.1 Allergan
12.1.1 Allergan Company Details
12.1.2 Company Description and Business Overview
12.1.3 Glaucoma Therapeutics Introduction
12.1.4 Allergan Revenue in Glaucoma Therapeutics Business (2014-2019)
12.1.5 Allergan Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 Glaucoma Therapeutics Introduction
12.2.4 Pfizer Revenue in Glaucoma Therapeutics Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Glaucoma Therapeutics Introduction
12.3.4 Novartis Revenue in Glaucoma Therapeutics Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Glaucoma Therapeutics Introduction
12.4.4 Merck Revenue in Glaucoma Therapeutics Business (2014-2019)
12.4.5 Merck Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details